Role of Tie‐2 Axis in Sepsis: A Potential Therapeutic Target
Open Access
- 22 October 2025
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (20) , e70912
Abstract
The angiopoietins (Angs)–Tie‐2 axis initiates signalling pathways that modulate vascular stability and angiogenesis and plays an important role in a variety of physiological and pathological processes, including inflammation, wound healing and cancer, by regulating endothelial cell proliferation, survival, migration, invasion and/or differentiation. Disruption of Ang‐1/2 and the Tie‐2 receptor can lead to endothelial cell activation or dysfunction, which can contribute to the pathogenesis of sepsis. Although the mechanisms by which the Ang–Tie‐2 axis participates in sepsis pathogenesis have not been fully elucidated due to the dynamic and complicated nature of sepsis, Ang–Tie‐2 axis malfunction causes endothelial cell activation and contributes to sepsis pathogenesis. During the initiation and development of sepsis, endothelial cells secrete Ang‐2, which inhibits Tie‐2 activation and subsequent signalling, leading to endothelial damage, increased vascular permeability, exacerbated inflammation and multiorgan injury. In this review, we summarise the latest advances in basic and clinical research on relevant papers from the PubMed database. We aim to offer a comprehensive overview of the current state of the art of the Ang–Tie‐2 axis in the context of sepsis and to explore the potential therapeutic targets for treating sepsis. A better understanding of the regulatory mechanisms related to the Ang–Tie‐2 axis could help identify potential therapeutic targets for treating sepsis.Keywords
Funding Information
- Natural Science Foundation of Hubei Province (2022CFB148)
This publication has 100 references indexed in Scilit:
- Endothelial dysfunction: Pathophysiology and therapeutic targets for sepsis-induced multiple organ dysfunction syndromeBiomedicine & Pharmacotherapy, 2024
- Circulating Biomarkers of Endothelial Dysfunction Associated With Ventilatory Ratio and Mortality in ARDS Resulting From SARS-CoV-2 Infection Treated With Antiinflammatory TherapiesCHEST Critical Care, 2024
- Therapeutic targeting of angiopoietins in tumor angiogenesis and cancer developmentBiochemical and Biophysical Research Communications, 2023
- Precision fluid and vasoactive drug therapy for critically ill patientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsisCytokine, 2020
- Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patientsBJS Open, 2020
- The Angiopoietin-Tie2 Pathway in Critical IllnessCritical Care Clinics, 2020
- Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cellsResearch and Practice in Thrombosis and Haemostasis, 2019
- Vasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in ratsBritish Journal of Anaesthesia, 2018
- Role of angiopoietin-2 in infection – A double-edged sword?Cytokine, 2016